Rania Kronfli

Ms. Rania Kronfli


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
RKRania Kronfli
Rania Kronfli
MDMark Davenport
Mark Davenport

18 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DJDeepak Joshi
Deepak Joshi
TSTaimur Tariq Shafi
Taimur Tariq Shafi
UAUsama Al-Farsi
Usama Al-Farsi
MKMargaret G Keane
Margaret G Keane
TGTassos Grammatikopoulos
Tassos Grammatikopoulos
PHPhillip Harrison
Phillip Harrison
Objectives: To evaluate the role of ERCP (endoscopic retrograde cholangio-pancreatography) and EUS (endoscopic ultrasound) and to describe the efficacy and safety of these procedures in a paediatric cohort with chronic pancreatitis (CP) and acute recurrent pancreatitis (ARP). Methods: All patients (<18 years) undergoing an ERCP or EUS for ARP and CP between January 2008 and December 2022 were included. Data collection included indications for the procedure, technical success, adverse events and outcome data. Results: A total of 222 ERCPs were performed in 98 patients with CP and ARP (60% female, median age 10 years). The commonest indications were a main pancreatic duct stricture (PD) with or without a stone within the main PD. Successful cannulation was achieved in 98% of cases. Improved stricture resolution was demonstrated in 63% of patients. The overall adverse event rate for ERCP was low (n = 8/222, 3.6%). An improvement in abdominal pain was demonstrated in (75/98) 76% of patients. Their Body Mass Index also significantly improved post ERCP (15.5 ± 1.41 vs. 12.9 ± 1.16 kg/m2, p = 0.001). A total of 54 EUS procedures were undertaken in 48 individuals. Moreover, 35 individuals underwent a therapeutic EUS procedure, for which the commonest indication was the drainage of a pancreatic fluid collection. The overall complication rate was low (n = 2.4%) in all EUS cases. Conclusions: ERCP and EUS can be safely and effectively used in a paediatric population with indications analogous to an adult cohort.

24 October 2026 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
EJEleanor Jeffreys
Eleanor Jeffreys
AJAllan Jenkinson
Allan Jenkinson
RKRania Kronfli
Rania Kronfli
JBJennifer Billington
Jennifer Billington
RBRavindra Bhat
Ravindra Bhat
CHChristopher Harris
Christopher Harris
This study aims to evaluate changes in outcomes and management of infants with severe congenital diaphragmatic hernia (CDH) undergoing fetoscopic endoluminal tracheal occlusion (FETO) across two eras, and to compare outcomes by side of defect over the last decade. Retrospective review of liveborn infants with severe CDH (observed to expected lung to head ratio [O/E LHR] < 0.25 left-sided; < 0.45 right-sided) who underwent FETO at King’s College Hospital, London, UK, and survived to delivery. Fifty-eight infants were included across two 5-year periods (2002–2007 and 2020–2025). Survival improved from 44.1% to 70.8% ( p = 0.044). Right-sided defects were more common in the second epoch (9% versus 54%, p < 0.001). All infants in the second era had echocardiography-guided inotropic and ventilatory management, which was not universally available earlier. In the second epoch surgical repair occurred later (4.0 versus 6.5 days, p = 0.018), repair by two-stage abdominal closure (laparostomy) increased from 0% to 77.8% ( p < 0.001) and recurrence fell from 33 to 0% ( p = 0.042). Mechanical ventilation, oxygen therapy and admission were longer latterly. In thirty-one infants delivered between 2015 and 2025, preterm prelabour rupture of membranes (PPROM) occurred in 67% of left-versus 92% of right-sided CDH, but at an earlier gestational age in left ( p = 0.032). Left CDH infants had longer duration of mechanical ventilation ( p = 0.04) and hospital stay ( p = 0.006) with no mortality difference (exploratory). Conclusion : Survival of FETO-treated severe CDH infants improved from 44 to 71% alongside later repair, staged abdominal closure and echocardiography-guided management. Left-sided defects had greater respiratory morbidity and longer admission than right-sided defects without changing survival. What is Known :• FETO improves survival in severe left-sided CDH, but postnatal management has changed substantially since its introduction. What is New :• Survival of FETO-treated severe CDH rose from 44 to 71% over two decades despite more right-sided defects. Repair occurred later, following haemodynamic and respiratory stabilisation (as guided by echocardiography) with staged abdominal closure in 77.8% of recent repairs; recurrence decreased from 33 to 0%.• Left-sided CDH infants had greater respiratory morbidity and length of stay than right-sided CDH infants, without a significant difference in mortality.

8 May 2019
Verified
Book Chapter
Closed access
PDF file
RKRania Kronfli
Rania Kronfli